Showing results (541-550 of 829) with videos related to

Sort By:
Pageof 83
Clinical Science (London, England : 1979)|September 29, 2004
Cardiovascular risk factors and endothelial dysfunctionAnthony S Wierzbicki, Philip J Chowienczyk, John R Cockcroft, et al.
Journal of Lipid Research|June 23, 2009
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-IIIDoris T Chan, Gursharan K Dogra, Ashley B Irish, et al.
Journal of Lipid Research|January 1, 1993
Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemiaT Demant, A Gaw, G F Watts, et al.
European Journal of Clinical Investigation|April 1, 1996
Acute hyperinsulinaemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjectsR P Naoumova, M H Cummings, G F Watts, et al.
Metabolism: Clinical and Experimental|April 3, 2020
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)Gerald F Watts, Dick C Chan, Jing Pang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 31, 2001
Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potentialG Dogra, N Ward, K D Croft, et al.
Asia Pacific Journal of Clinical Nutrition|November 29, 2007
Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndromeEsther M M Ooi, Gerald F Watts, P Hugh R Barrett, et al.
Pageof 83